Søgning
Søgning på udtrykket 'immun' giver 73 resultater
Dokumenter [17]
Sider [6]
Kalender [7]
Nyt fra tidsskrifterne [+20]
Aktuelle smitsomme sygdomme [+20]
Denne vejledning omhandler vurdering og behandling af tuberkuloseinfektion hos voksne, som skal behandles med immunsupprimerende medicin i form af f.eks TNF-α hæmmere eller andre immunsupprimerende biologiske lægemidler, hvor der er øget risiko for tuberkulosereaktivering.
Guideline dækker ikke børn, personer med medfødt immundefekt, HIV positive, patienter i dialyse, patienter med dysreguleret diabetes, silicose, erhvervede immundefekter eller patienter i konventionel kortvarig kemoterapi.
Denne g…
Gå til www.immundefekt-diagnostik.dk
Udarbejdet af en arbejdsgruppe bestående af immunologer, pædiatere og infektionsmedicinere
National klinisk guideline, Dansk Selskab for Gastroenterologi og Hepatologi (DSGH), Dansk Selskab for Klinisk Immunologi (DSKI), Dansk Selskab for Klinisk Mikrobiologi (DSKM) og Dansk Selskab for Infektionsmedicin (DSI)
r (BMSL) til patienter i forhold til risiko for tuberkulose (TB), Humant Papillom Virus (HPV), Hepatitis B og C (HBV og HCV), Varicella Zoster Virus (VZV), Herpes Simplex Virus (HSV), Cytomegalovirus (CMV), Epstein Barr Virus (EBV) og Humant Immundefekt Virus (HIV) og øvrige infektioner.
Vejledningen er udarbejdet af repræsentanter fra Dansk Selskab for Gastroenterologi og Hepatologi (DSGH), Dansk Reumatologisk Selskab (DRS), Dansk Dermatologisk Selskab (DDS) og Dansk Selskab for Infektionsmedicin (DSI).
Udarbejdet af arbejdsgruppe fra Dansk Selskab for Infektionsmedicin og Dansk Fertilitetsselskab.
Udarbejdet af en arbejdsgrupper bestående af medlemmer fra Dansk Selskab for Infektionsmedicin og Dansk Transplantationsselskab
Denne vejledning er tiltænkt behandling af CVID hos voksne patienter.
Den aktuelle udgave er opdateret med anvendelse af PCV20.
Denne vejledning er tiltænkt diagnostik og kontrol af CVID hos voksne patienter.
Den aktulle udgave er opdateret med PCV20.
Udarbejdet af DSI's arbejdsgruppe vedrørende antiretroviral terapi
Rekommandationer for profylakse og vaccination ved aspleni.
Denne vejledning dækker anbefalinger omhandlende vaccinationer, antibiotika profylakse og patientinformation om generelle forholdsregler for at beskytte personer med aspleni mod infektioner.
Version 1.2, 22.10.2024. Ændringer siden version 1.1:
Vaccination mod Haemophilus influenzae ændret til 1 dosis (fejlagtigt angivet 3 doser).
Menveo beskytter efter 1 dosis (fejlagtigt angivet som nødvendigt med 2…
Denne vejledning er tiltænkt diagnostik og behandling af COVID-19. Denne retningslinje vil løbende blive opdateret, som ny evidens kommer frem.
Ændringer siden version 29:
Indikationer for COVID-19 test er tilføjet.
Udarbejdet af Dansk Selskab for Infektionsmedicin i samarbejde med Dansk Selskab for Klinisk Mikrobiologi, Dansk Hæmatologisk Selskab, Dansk Pædiatrisk Selskab, Dansk Selskab for Almen Medicin, Dansk Lungemedicinsk Selskab, Dansk Selskab for Obstetrik og Gynækologi, Dansk Transplantationsselskab, Dansk Selskab for Klinisk Onkologi, Statens Serum Institut & Fagligt Selskab for Hygiejnesygeplejersker
Bl.a. om HIV, hepatitis, resistente bakterier og immundefekt
Bl.a. om hepatitis, emerging viruses og immundefekt
Bl.a. om primær og sekundær immundefekt, vaccinationer og visioner for specialet
Specialebeskrivelse:
Infektionsmedicin er et tværgående klinisk speciale, der omfatter undersøgelse og behandling af patienter med hjemlige og importerede infektionssygdomme hos både immunkompetente og immundefekte personer. Specialet rådgiver omkring forebyggelse af infektioner af betydning for den almindelige folkesundhed, og yder lægefaglig rådgivning vedrørende profylaktiske foranstaltninger i forbindelse med udlandsophold…
od HIV (2021),
HIV komorbiditeter:
Lene Ryom (tovholder), Bo Hønge, Sanne Jespersen, Daria Podlekareva, Steffen Leth, Michael Dalager-Pedersen, Ole Kirk, Camilla Ingrid Hatleberg, Raquel Iguacel, Susanne Dam Poulsen, Ann-Brit Eg hansen…
2 dage):
Sted.
Aarhus Universitetshospital (AUH) .
Delkursusledelse.
Ole Schmeltz Søgaard og Lene Ryom Nielsen .
Program.
Afventer.
Tidligere kurser.
12. og 13. oktober 2022.
7. og 8. oktober 2019.
3. og 4. oktober 2016.
Immundefekt og feber af ukendt årsag:
Dato for næste kursus.
2026:
Sted.
Infektionsmedicinsk afd. 8632, Rigshospitalet.
Delkursusledelse.
Marie Helleberg og Trine Mogensen.
Program.
Afventer.
Tidligere kurser.
30. og 31…
Specialebeskrivelse:
Infektionsmedicin er et tværgående klinisk speciale, der omfatter undersøgelse og behandling af patienter med hjemlige og importerede infektionssygdomme hos både immunkompetente og immundefekte personer. Specialet rådgiver omkring forebyggelse af infektioner af betydning for den almindelige folkesundhed, og yder lægefaglig rådgivning vedrørende profylaktiske foranstaltninger i forbindelse med udlandsophold…
Welcome to the website of the Danish Society of Infectious Diseases (DSI).
The site contains guidelines, news about infectious diseases and information about upcoming events of relevance.
At present, most of the information is only available in danish. But please feel free to contact any member of the Board listed below for information about DSI and its activities.
The Board:
Lars Skov Dalgaard. Chair. forperson@infmed.dk.
Christian Kraef. Deputy chair. naestformand@infmed.dk.
Secretary…
Odgaard.
15.30-16.00 Quiz-gennemgang/ Lotte Ebdrup og Pernille Ravn.
16.00-16.15 Evaluering, Lotte Ebdrup og Pernille Ravn.
.
Litteratur:
1) Guideline, Spondylodiskitis, Dansk Selskab for Infektionsmedicin.
2) Darenberg et al, Intravenous Immunoglobulin G Therapy in STSS: A European Randomized, Double-Blind, Placebo-Controlled Trial, CID 2003;37:333.40…
er som følger: 1) Det vises for første gang, at et medikament kan reaktivere latent HIV-virus under samtidig HAART-behandling i en grad, så virus kan påvises i perifert blod. 2) Der er (omend videnskaligt svage) indicier på, at HIV-reservoir kan reduceres hos nogle patienter, og at effekten af det innate immunforsvar er af betydning herfor. 3) Det er den første originalartikel trykt i den allerførste udgave af et helt nyt HIV-tidsskrift (som formentlig vil blive et betydende tidsskrift på området).
ynes at være lige god i alle aldersgrupper. Patienter med svækket immunsystem kan vise sig at have ringere effekt end forsøgspersonerne i studiet. Varigheden af beskyttelse er af indlysende grunde ikke kendt endnu, tidligere har mRNA-vaccine teknologi haft udfordringer med hastigt aftagende antistof niveau. Sjældne bivirkninger opdages ikke nødvendigvis i registreringsstudier.
Disse forbehold betyder er der er meget brug for en intensiv overvågning af vaccinens virkning og bivirkning de kommende år.
an klinisk manifestere sig fra asymptomatisk til fibrose, cirrose og hepatocellulært carcinom.
Trods forekomst af en effektiv vaccine i mere end 40 år, lever 296 millioner mennesker globalt med kronisk hepatitis B, heraf estimerede 14.500 i Danmark. Aktuelt er eneste behandlingstilbud (ofte livslang) antiviral terapi.
Denne artikel gennemgår naturhistorien, kendte og nye biomarkører, inklusive surrogatmarkører for cccDNA transkription, samt nye terapiformer som siRNA, CAMs og immunmodulerende terapi.
14. oktober 2026, Maastricht, Holland
6. maj 2026, New Orleans, Louisiana, USA
15. april 2026, Boston, Massachusetts, USA
5. november, Prag, Tjekkiet
3. september, Båstad, Sverige
28. maj, Panum Instituttet, København
Nyt fra tidsskrifterne [+20]
Der er mere end 20 resultater, måske du vil se flere resultater her?
PLoS One Infectious Diseases
24.05.2025
by The PLOS One Editors .
Journal of Medical Virology
23.05.2025
Journal of Medical Virology, Volume 97, Issue 5, May 2025.
PLoS One Infectious Diseases
23.05.2025
by Razia Liaqat, Shafaq Fatima, Wajeeha Komal, Qandeel Minahal . The present study assessed the effects of methionine, lysine, and tryptophan on the growth performance, amino acid composition, and immune-related gene expression of basa catfish (Pangasius bocourti)…
Lancet Infectious Diseases
22.05.2025
RIV4 induced non-inferior immune responses in the participants aged 9–17 years compared with those aged 18–49 years. No safety concerns were reported.
Journal of Infectious Diseases
21.05.2025
BMC Infectious Diseases
20.05.2025
. Background. Disseminated varicella infection in adults, particularly those with mild immunosuppression, can lead to severe complications and life-threatening outcomes. Early diagnosis and intervention are critical yet challenging due to atypical presentations. . Case presentation…
Proceedings of the National Academy of Sciences: Immunology and Inflammation
20.05.2025
Proceedings of the National Academy of Sciences, Volume 122, Issue 21, May 2025.
PLoS One Infectious Diseases
20.05.2025
by Marlou J. Jongkees, Susanne Bogers, Rory D. de Vries, Corine H. GeurtsvanKessel, Pedro Miranda Afonso, Kathryn S. Hensley, Bart J. A. Rijnders, Kees Brinkman, Casper Rokx, Anna H. E. Roukens . Background Although guidelines for COVID-19 additional vaccination strategies generally prioritise people with advanced HIV infection, recommendations vary globally, with some countries recommending an annual vaccination for all people with HIV (PWH), while others restrict this to PWH with a CD4+ T-cell count
Frontiers in Immunology
19.05.2025
Mature dendritic cells release exosomes; however, the immunological role of exosomes in dendritic cell vaccine therapy remains unclear. We examined the immunogenicity of neoantigen peptide-pulsed dendritic cell-derived exosomes (Neo-P DEX) and investigated their role in vaccine therapy. The quality of DEX derived from dendritic cell cultures was confirmed via electron microscopy, western blotting, flow cytometry, and CD63 ELISA…
PLoS One Infectious Diseases
17.05.2025
by K. G. Aghila Rani, Ali Al Qabbani, Sausan AlKawas, Manju Nidagodu Jayakumar, S. A. H. Suzina, A. R. Samsudin, Ahmad Azlina . The immunological sensitization of implanted bone grafts is crucial for long-term success…
Clinical & Experimental Immunology
15.05.2025
BMJ Open
15.05.2025
d frailty may all be contributing factors to PPCs. Poor oral hygiene is a risk factor for PPC as well, as oropharyngeal microflora might be introduced to the lower respiratory tract following endotracheal intubation for general anaesthesia during surgery. Immune regulation, nutrition supplementation and improvement of oropharyngeal microflora might regulate immune and stress response and can be beneficial to elderly patients exposed to surgical stress…
Clinical Infectious Diseases
15.05.2025
PLoS One Infectious Diseases
15.05.2025
hen Wang, Qinchao Wu, Jie Chen, Jun Wang, Dan Li . Kawasaki disease (KD) is an acute vasculitis that primarily affects children under five and is a leading cause of acquired heart disease in this age group. Despite the standard treatment with intravenous immunoglobulin (IVIG), approximately 10–20% of patients exhibit IVIG resistance, leading to persistent inflammation and an increased risk of coronary artery aneurysms(CAA)…
Journal of Medical Virology
15.05.2025
Journal of Medical Virology, Volume 97, Issue 5, May 2025.
Journal of Infectious Diseases
14.05.2025
Journal of Infectious Diseases
14.05.2025
Abstract . Background . Measles-Mumps-Rubella (MMR) is an effective live-virus vaccine against measles but is poorly immunogenic in infants and contraindicated for pregnant and immunocompromised persons.Methods . We evaluated immunogenicity and protective efficacy of a novel recombinant dimeric MeV hemagglutinin protein vaccine (rMeV) in rhesus macaques…
Proceedings of the National Academy of Sciences
14.05.2025
Proceedings of the National Academy of Sciences, Volume 122, Issue 19, May 2025. We have generated a single-cell RNA sequencing atlas of peripheral blood and ventricular CSF in idiopathic normal pressure hydrocephalus (iNPH) patients totaling 140,207 single-cell transcriptomes. We found proinflammatory alterations in peripheral blood .
PLoS One Infectious Diseases
14.05.2025
rtive care; however, the success of these treatments remains limited. Therefore, this study investigated the potential of Atractylodes lancea (Thunb) D.C. (AL) in limiting the progress of CCA by targeting the expression of cancer-related genes involved in immune responses and circulating tumor cells…
Clinical Microbiology and Infection
13.05.2025
between the generation of reliable scientific evidence and the urgent clinical needs of patients, particularly those exhibiting significant, albeit led prevalent, comorbidities. This temporal lag frequently resulted in therapeutic decision-making under conditions of evidentiary scarcity. Immunocompromised individuals exhibit an elevated susceptibility to SARS-CoV-2 infection. However, the intersection of specific immunosuppressive comorbidities and COVID-19 is rarely characterized within COVID-19 research.
Aktuelle smitsomme sygdomme [+20]
Der er mere end 20 resultater, måske du vil se flere resultater her?
Medscape Infectious Diseases
1.05.2025
Tetanus-diphtheriaa-acellular pertussis–inactivated polio virus vaccination during pregnancy is safe and boosts pertussis-specific antibody responses in infants. . Medscape Medical News
WHO Eastern Mediterranean Region news
23.04.2025
. 23 April 2025, Cairo, Egypt – World Immunization Week 2025, observed from 24–30 April, brings together the global health community to highlight the lifesaving power of vaccines and call for renewed commitment to immunization for all. . Under the banner Immunization for All is Humanly Possible, this year’s campaign stresses how, with collective efforts and investment, everyone can be protected from vaccine-preventable diseases. . Vaccines are one of the humanity’s greatest achievements…
Medscape Infectious Diseases
16.04.2025
The Oncohaematological Immunoprevention Unit in Madrid combines AI and multidisciplinary care to detect immunodeficiencies early, reducing cancer patients’ risk for infections and improving recovery. . Medscape News UK
Eurosurveillance latest updates
11.04.2025
embling the diphtheria–tetanus–pertussis vaccine coverage in Lombardy for this population, was estimated to avert 30.5% (95% CI: 19.6–39.7) of hospitalisations. At influenza vaccine coverage (12%), less than 8% of hospitalisations could be averted by maternal immunisation. . . Conclusion. Routine nirsevimab administration to infants demonstrates clear potential to reduce RSV-associated hospitalisations. Maternal immunisation can help in achieving high protection in at-risk populations. . . .
Eurosurveillance latest updates
14.02.2025
Using real-life data from Spain between October 2023 and March 2024, the number needed to immunise (NNI) with nirsevimab and the cost to prevent one RSV hospitalisation were estimated at 90 infants (95% CI: 77–108) and 19,700 EUR for catch-up immunisation, and 41 infants (95% CI: 35–50) and 9,000 EUR for at-birth immunisation. By month of birth, NNI and cost were lowest in infants born shortly before the RSV epidemic peak, with impact decreasing gradually for earlier or later births. .
Eurosurveillance latest updates
8.02.2025
. Background. Respiratory syncytial virus (RSV) causes substantial morbidity in infants
Morbidity and Mortality Weekly Report (MMWR)
17.01.2025
This report describes CDC's 2025 immunization schedule for adults aged 19 years and older.
Morbidity and Mortality Weekly Report (MMWR)
17.01.2025
This report describes CDC's 2025 immunization schedule for children and adolescents aged 18 years or younger.
Morbidity and Mortality Weekly Report (MMWR)
9.01.2025
This report describes CDC's updated pneumococcal conjugate vaccine recommendation for all adults aged ≥50 years who are PCV-naïve or who have unknown vaccination history.
Medscape Infectious Diseases
24.12.2024
Recombinant pertussis booster vaccines provided sustained immunity against whooping cough in adolescents and young adults, showed a recent follow-up study of a clinical trial. . Medscape Medical News
Morbidity and Mortality Weekly Report (MMWR)
13.12.2024
This report describes CDC's updated recommendations for the MenB-4C vaccine to align the dosing interval and schedule with the new FDA label.
Morbidity and Mortality Weekly Report (MMWR)
13.12.2024
This report describes CDC's recommendation that all people aged ≥65 years and people ages 6 months-64 years with moderate or severe immunocompromise receive a second 2024-2025 COVID-19 vaccine dose 6 months after their last dose.
Morbidity and Mortality Weekly Report (MMWR)
15.11.2024
This report describes instances of positive measles immunoglobulin tests among two children in American Samoa that were later confirmed to be alternative viral etiologies.
Medscape Infectious Diseases
15.11.2024
In hospitalized patients, eosinophil levels positively correlated with antibiotic use, systemic inflammation, and worsened outcomes. . Medscape Medical News
Medscape Infectious Diseases
29.10.2024
CDC's Jarrett Gartin shares what healthcare providers should know about RSV vaccine recommendations for patients vulnerable to infection. . CDC Expert Commentary
Medscape Infectious Diseases
11.10.2024
Only 13.4% immunocompromised adult US veterans younger than 50 years received the recombinant zoster vaccine by mid-2023, which reflected a lag in the adoption of revised national recommendations. . Medscape Medical News
Morbidity and Mortality Weekly Report (MMWR)
27.09.2024
This report describes estimated childhood vaccination coverage among children born during 2020-2021.
Medscape Infectious Diseases
19.09.2024
British drugmaker GSK said on Wednesday administration of its respiratory syncytial virus (RSV) vaccine and shingles shot together generated the same immune response in a. . Reuters Health Information
Statens Serum Institut
13.09.2024
En ekstra vaccination mod covid-19 giver en markant sundhedsgevinst til immunsvækkede personer, viser en ny nordisk undersøgelse, som Statens Serum Institut (SSI) har ledet.
Morbidity and Mortality Weekly Report (MMWR)
13.09.2024
This report describes the Advisory Committe on Immunization Practices recommendation for use of Haemophilus influenzae type b (Hib) vaccine for American Indian and Alaska Native infants.